In Pursuit of Sustainable Development of Talents and Products
Corporate Social Responsibility Honors and Ratings
- MSCI ESG Rating A
- HSIESG Rating A-
- Top 30 ESG Excellent Practices（ China Media Group）
- Outstanding Responsible Enterprise of 2023（People's Daily Online）
- the Most Admired Chinese Companies of 2023（ Fortune magazine）
Our Stories
-
-
Safeguarding health of grassroots, empowering rural doctors and supporting rural revitalization
-
Safeguarding health of grassroots, empowering rural doctors and supporting rural revitalization
Fosun Pharma deeply involved in the Rural Doctor Project, actively supported and protected rural doctors, empowered the construction of rural medical system, promoted rural revitalization, and improved the livelihood of rural citizens. .As at the end of 2023, the project covered 78 key counties receiving assistance in 16 provinces, cities and autonomous regions, with 366 person head dispatched to station in counties receiving assistance in aggregate,thereby protecting 24,000 rural doctors and benefitting 3 million rural families. In 2023, the “Hand in Hand” Rural Medical Talent Revitalization Plan focused on the integration of Chinese and western medicine. Through online “Doctors’ Lectures” and offline “Famous Doctors Visiting Rural Areas” campaigns, this plan gathered famous domestic medical experts in Chinese and western medicine to visit remote rural areas and commenced targeted medical assistance. By exporting medical technologies and integrating Chinese and western medicine, we practically assisted rural doctors to improve their diagnosis skills.
On 19 October 2023, Foshan Fosun Chancheng Hospital and Shenzhen Hengsheng Hospital, both subsidiaries of the Company, were granted the title of “Healthy and Heart-Warming Rural Doctor Training Base”.As at the end of the Reporting Period, Foshan Fosun Chancheng Hospital has successfully conducted three sessions of rural doctor training class. During the training, the lecturers provided customized learning program for rural doctors, making them able to apply what they have learned and provide better medical services for grassroots
-
-
-
"Two Cancers screening program" for grassroots
-
"Two Cancers screening program" for grassroots
On 16 September 2023, Fosun Pharma and Shanghai Soong Ching Ling Foundation jointly launched the “Pink Blue Ribbon Charity Program” at Xishuangbanna Maternal and Child Health Hospital in Yunnan. Designed to expand the screening coverage for two primary cancers among women in Xishuangbanna and boost the primary medical level, the program offered free breast and cervical cancer screening services for more than 16,000 women in Xishuangbanna. National well-known medical experts were invited to provide free consultation, training, tutoring and instructions in the locality. Meanwhile, we donated our intelligent screening solution for the two cancers to improve local medical accessibility. Fosun Pharma also plans to provide free opportunities for local doctors to study in Grade A tertiary hospitals in Shanghai and Foshan, thus effectively improving the diagnosis and treatment capabilities of doctors in Xishuangbanna.
Fosun Pharma hopes to leverage its strengths to safeguard women's health. Meantime, it will better support Shanghai-Yunnan cooperation, opening a new chapter of public welfare cooperation between Shanghai and Xishuangbanna.
-
-
- released the 1st
- ESG and Sustainability Report
-
- 40370
- Global job creation
-
- 49.53 %
- percentage of female employees
-
- 46 million
- public welfare donations in 2023
-
- Over 230 million
- EHS investment
-
- 68 million
- severe malaria patients treated with artesunate